QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
39.69 ^USD	-2.77%		+3.74%	-46.15%

Apr. 02	QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	MT
Apr. 02	QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	MT

Quidel Corporation(NasdaqGS:QDEL) added to Russell 3000 Value Index

June 25, 2021 at 12:00 am EDT

Latest news about QuidelOrtho Corporation

QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	Apr. 02	MT
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	Apr. 02	MT
QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test	Apr. 02	CI
QuidelOrtho Receives Canada's Approval for Triage PLGF Test to Detect Pregnancy Complications	Mar. 06	MT
Transcript : QuidelOrtho Corporation Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 04:00 PM	Mar. 05
Sector Update: Health Care Stocks Mixed Late Afternoon	Mar. 04	MT
Sector Update: Health Care	Mar. 04	MT
QuidelOrtho Shares Decline Following UBS Downgrade	Mar. 04	MT
UBS Downgrades QuidelOrtho to Sell From Neutral, Adjusts Price Target to $42 From $70	Mar. 04	MT
Sector Update: Health Care Stocks Mixed in Late Afternoon	Feb. 21	MT
Sector Update: Health Care	Feb. 21	MT
QuidelOrtho Terminates CEO Douglas Bryant, Postpones Investor Day	Feb. 21	MT
QuidelOrtho Corporation Announces CEO Changes	Feb. 21	CI
QuidelOrtho Corporation Announces Changes in Executive Leadership, Effective from February 21, 2024	Feb. 21	CI
Sector Update: Health Care Stocks Gain Late Afternoon	Feb. 14	MT
Sector Update: Health Care Stocks Rise in Afternoon Trading	Feb. 14	MT
Top Midday Decliners	Feb. 14	MT
QuidelOrtho Shares Slump After Analysts Downgrade Stock Following Lower Q4 Results	Feb. 14	MT
William Blair Downgrades QuidelOrtho to Market Perform From Outperform	Feb. 14	MT
Citigroup Adjusts Price Target on QuidelOrtho to $50 From $72, Maintains Neutral Rating	Feb. 14	MT
Craig-Hallum Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $50 From $158	Feb. 14	MT
Raymond James Downgrades QuidelOrtho to Outperform From Strong Buy, Cuts Price Target to $76 From $100	Feb. 14	MT
Sector Update: Health Care Stocks Edge Higher Premarket Wednesday	Feb. 14	MT
JPMorgan Downgrades QuidelOrtho to Underweight From Neutral, Adjusts Price Target to $37 From $66	Feb. 14	MT
Sector Update: Health Care	Feb. 14	MT

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-07 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for QuidelOrtho Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

39.69 USD

Average target price

54.73 USD

Spread / Average Target

+37.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-46.15%	2.65B
SARTORIUS AG	-15.34%	18.55B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+14.09%	1.81B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.39%	1.61B
BIOTAGE AB	+23.19%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.58%	1.03B
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.72%	896M
REVENIO GROUP OYJ	-12.15%	680M
VAREX IMAGING CORPORATION	-17.56%	686M
PHC CO.,LTD.	-.--%	302M

Medical Diagnostic & Testing Equipment

QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Quidel Corporation(NasdaqGS:QDEL) added to Russell 3000 Value Index

Latest news about QuidelOrtho Corporation

Chart QuidelOrtho Corporation

Company Profile

Income Statement Evolution

Ratings for QuidelOrtho Corporation

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment